Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to fall 139.53% to 5 cents per share on August 18
Q2'26
Est.
$0.06
Q1'26
Missed
by $0.16
Q4'25
Est.
$0.01
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.15
The last earnings report on May 12 showed earnings per share of -15 cents, missing the estimate of 0 cents. With 2.08M shares outstanding, the current market capitalization sits at 6.74B.